Target WP4 - Ricapps

The network

research programme

02

WP 4. To develop and evaluate tools for early detection of non-transmissible diseases in primary care, and screening strategies and interventions for a secondary prevention of such diseases.

Coordinator

Rafel Ramos

CARDIOCAT Research Group (Girona)

RD24/0005/0001

rramos.girona.ics@gencat.cat

Participating Groups

Cardiocat. IP:

Rafel Ramos (RD24/0005/0001)

BIPS. IP:

Alvaro Sanchez (RD24/0005/0017)

GRAP-caIB. IP:

Alfonso Leiva (RD24/0005/0008)

GIAPCyL. IP:

Luis García (RD24/0005/0018)

Sant Joan de Deu. IP:

Montserrat Gil (RD24/0005/0007)

Canary Islands. IP:

Lilisbeth Perestelo (RD24/0005/0003)

Biosistemak - OSI Barrualde-Galdakao. IP:

Susana García (RD25/0005/0020)

IMIM. IP:

María Sala (RD24/0005/0002)

Valencia. IP:

Isabel Hurtado (RD24/0005/0009)

F. Avedis Donabedian. IP:

Carola Orrego (RD21/0001/0028)

GRenSSAP. IP:

Anna Berenguera (RD24/0005/0005)

Madrid-InSSEC. IP:

Isabel del Cura (RD24/0005/0015)

Hospital Costa del Sol. IP:

Maximino Redondo (RD24/0005/0016)

Biosistemak - OSI Bilbao-Basurto. IP:

Amaia Bilbao (RD24/0005/0019)

Research lines

Line 1 To design of tools for early detection and risk prediction of frequent and/or relevant diseases in secondary prevention and evaluation of the incorporation of new and innovative risk factors. Such methods will be developed, accounting for potential gender differences. These tools ease personalized interventions and enhance the longitudinal approach that characterizes primary care (PC). Detecting diseases at an early stage can be in great value in PC providing excellent care and optimization of healthcare resources to delay illness progression.

Task 1.To design tools for early detection of frequent and/or relevant diseases.

Task 2.To design tools for risk prediction in secondary prevention of frequent and/or relevant diseases.

Line 2 Screening strategies for early detection of frequent and/or relevant diseases in Primary Care during different stages of life. The development of such strategies will be contemplated, but a main focus will be placed on their implementation and the assessment of their effectiveness and cost-effectiveness. Coordination and integration between the different agents and healthcare professionals will be particularly considered through the implementation processes of these strategies. The identification of more effective and cost-effective screening strategies would mean detecting diseases at early stages, with direct impact on improving illnesses control, evolution, and prognostic.

Task 1. To design strategies for screening and early detection of frequent and/or relevant diseases.

Task 2. To implement strategies for screening and early detection of frequent and/or relevant diseases into clinical practice in Primary Care.

Task 3. To evaluate the effectiveness and cost-effectiveness of strategies for screening and early detection of frequent and/or relevant diseases.

Line 3 Pharmacological and non-pharmacological interventions for secondary prevention of frequent and/or relevant diseases at different stages of life. Studies will be centred in assessing their effectiveness and cost-effectiveness and their implementation. The design of secondary prevention interventions will also be conducted. The impact of these studies is expected to reduce incidence of new events or worsening of the prevalent conditions. Intervening on high-risk patients in secondary prevention improves health resources allocation while it benefits on patient’s health, reducing health inequities.

Task 1. To design pharmacological and non-pharmacological interventions in secondary prevention.

Task 2. To implement pharmacological and non-pharmacological interventions in secondary prevention into clinical practice in Primary Care.

Task 3. To evaluate the effectiveness and cost-effectiveness of pharmacological and non-pharmacological interventions in secondary prevention.